Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
58,272,553
-
Total 13F shares
-
18,235,433
-
Share change
-
-214,618
-
Total reported value
-
$420,211,308
-
Price per share
-
$23.95
-
Number of holders
-
65
-
Value change
-
-$5,994,881
-
Number of sells
-
3
Institutional Holders of AGIOS PHARMACEUTICALS, INC. - Common stock, par value $0.0001 per share (AGIO) as of Q4 2013
As of 31 Dec 2013,
AGIOS PHARMACEUTICALS, INC. - Common stock, par value $0.0001 per share (AGIO) was held by
65 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,235,433 shares.
The largest 10 holders included
Third Rock Ventures, LLC, Flagship Ventures 2007 General Partner LLC, FMR LLC, WELLINGTON MANAGEMENT CO LLP, BlackRock Fund Advisors, BROOKSIDE CAPITAL MANAGEMENT LLC, FRANKLIN RESOURCES INC, JENNISON ASSOCIATES LLC, FEDERATED INVESTORS INC /PA/, and Clearbridge Investments, LLC.
This page lists
65
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.